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Two monoclonal antibodies, HD 66 and CRIS-4, by which the new CD 76 B-cell-associated cluster was defined, bound to several gangliosides 
(sialic acid containing glycolipids) of different polarity. One of the gangliosides recognized by HD 66 could be identified as NeuAcuZ6Gal#Il- 
4CI1cNAc$I -3Gal/Il-4Glc-/?I-1’Cer. This antigen was enxymatically synthesized, Sialidase treatment of the ganglioside antigens abolished binding 
of HD 66 and CRIS-4, 
2,~~ia~o~llacton~tetraosyi~ra~d~ S~~y~ation~ CD 76; 3 lymphocyte; ~~~os~ng; Carbohydrate antigen 
Monoclonal antibodies (mAbs) directed against 
human leucocytes are classified in 78 clusters of dif- 
ferentiation (CD) by their binding profiles with various 
types of leucocytes and their recognition of identical 
antigens 111. Two monoclonal antibodies, HD 66 and 
CRIS-4, define the recently designated CD 76 antigen 
/2]. This antigen is present on mature human B lym- 
phocytes and some B-cell leukemia% a subpop~a~on 
of T lymphocytes, and some epithelial cell types [3]. We 
now show that both CD 76 mAb - though to different 
extents - recognize sialylated type 2 chain carbohydrate 
moieties of glycosphingolipids (GSLs) such as 
IV’NeuAcnLcKer. In contrast to CD 77 mAbs, which 
recognize the neutral GSL globotriaosylceramide (Gb3) 
on activated B-cells [3], CD 76 mAbs bind to sialylated 
GSLs on resting B-cells. Thus CD 76 mAbs detect a fur- 
ther cell specific carbohydrate surface antigen on 
human leucocytes like CDw 60, CDw 65 and CD 77 
mAbs [3-S]. 
column with 2OmM ammonium acetate in methanof. 
2,6-SiaLosy1lactoneotetraosylceramide (IVsNeuAcnLc&er) was 
prepared enzymatically as follows: a solution of 10,~ (8 nmol) lac- 
toneotetraosylceramide in 200~1 methanol was taken to dryness at 
ambient temperature in a well of a 4-well cell culture plate (Nunc, 
Wiesbaden, FRG). The adsorbed GSL was incubated with 140 nmol 
[‘4CJ-CMP-N-acetyl-neuraminic acid (1 ,&i/140 nmol) in 200 pl 
100 mM Mes buffer (2-(N-morpholino)ethanesulfonic a id), pH 6.5, 
containing 0.02% (w/v) sodium azide, 2.5 mM M&la, O.lW (w/v) 
bovine serum albumin and 5 mU of CMP-iv-acetyineuraminate:&D- 
galactosyl-1 ,~~~~ty~~-D-~uco~ne ~-2,~~~ce~lneuram~ny1- 
transferase @C 2.4.99.1) ~~h~~er Mannheim, M~h~rn~ FRG) 
at 37°C for 24 h. The incubation mixture was then removed and the 
remaining adsorbed GSL were extracted twice with l ml of methanol. 
The methanol extracts were dried, suspended under sonification in 
5 ml of 0.1 M aqueous KC1 and recombined with the incubation mix- 
ture. The solution was then purified on a Sep-Pak Cts cartridge 
(Millipore, Molsheim, France) as described [8]. Approximately 
43 700 cpm of the reaction product, corresponding to 4.8 pg of 
2,fWalosyllactoneotetraosylceramide (2,~WC) was obtained in the 
methanol eluate. 
2.2. Separation of GSL by HPLC 
2. MATERIALS AND METHODS 
HPLC of GSL was performed on a 16 x SO0 mm column f&d 
with Lichrosorb 8 60 (5 Frn particles) {Merck, Darmstadt, FRG). A 
linear gradient from ~pro~ol/~-h~~e/water (55 : 42 : 3 to 
f5:ZS :20) within 10 h at a ffow rate of 1.5 ml/m&r was used. 200 
fractions of 4.5 ml were collected. 
2.1. GIycosphingoifpids 
Lactoneotetraosylceramide was purified from human neutrophits 
by Folch partition [6J, DEAE Sepharose chromatography [7] and 
finally by high-performance liquid chromatography (HPLC) as 
described below. A monosialoganglioside fraction was prepared from 
unseparated human peripheral white blood cells and purified by 
Folch partition and DEAE Sepharose chromatography. 
Monosialogangliosides were eluted from the DEAE Sepharose 
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2.3. Sialidase treatment 
Sialidase treatment of gangliosides eparated on thin-layer plates 
(HPTLC Si 60, Merck, Darmstadt, FRG) was performed with 
10 mLJ/ml siahdase from Vibrio chokraet (MI 3.2.1.18; Behring, 
Marburg, FRO) in a 0.1% aqueous solution of CaClz at 37°C over- 
night. In addition, for sialidase treatment in vials, the gangliosides 
were sonicat9d briefly in 0.2 ml 0.1 Vo CaCla and then incubated with 
0.2 W (0.2 ml) Vibrio cholerae neuraminidase overnight at 37°C. In- 
cubation was stopped by addition of 2 ml chloroform/methanol (2 : 1 
V/V) yielding two phases. The lower phase contained the 
asi~og~gl~osides. 
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2.4. Antibodies 
MAb lB2 [9] detecting Gal&-4GlcNA@l-R was a kind gift of Dr 
K. Skubitz (Minneapolis, MN, USA); mAbs HD 66 [IO] and CRIS-4 
(R.Y.) were produced by the authors. 
Glycolipid antigens were detected on thin-layer chromatograms by 
immunostaining as described [ll] with some modifications [12]. In 
brief, after separation of the GSLs on HPTLC plates, the plates were 
coated with polyisobutylmethacryiate, blocked with PBS/l % BSA, 
and incubated with the antibody (Ii200 diluted ascites fluid) for I4 h 
at 4°C. After 4 washing steps, the HPTLC plate was treated with an 
1/‘K100 diluted phosphatase-labeled goat anti-mouse IgM antibody 
(Medac, Hamburg, FRG) for 90 min at 37°C in the presence of 3% 
(w/v) polyethylene glycol 6ooo. The plate was washed 4 times and 
finally overlaid with 0.5 m&ml 5-bromo-4chloro-3-indolyls 
phosphate (BCIP) in 100 mM giycine-NaOH buffer, pH 10.4, con- 
taining 1 mM MgQ and 1 mM Zn&i~. Glycolipid antigens are 
visualized by the appearance of a stable indigo-like stain with& 
30 min. 
2.6. GSL, staining 
Staining of GSLs on HPTLC plates was performed using an im- 
munochemical detection methad (in preparation). Briefly, after their 
HPTLC separation, the GSLs were oxidized directly on the 
~~~sobuty~methac~~ate-coats HPTLC plate with sodium 
periodate, incubated first with digoxigenin hydrazide, and then with 
a phosphatase-labeled polyclonal antibody recognizing digoxigenin. 
Bound antibodies were made visible with BCIP as described above. 
All reagents for this assay were abt,ained from Boehringer Mannheim 
(Mannheim, FRG). 
a b a b 
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F&t. Reactivity of mAb HD 66 with a g~g~oside of a HPLC- 
separated fraction (no.113) (see section 2) and the sialidase 
degradation product thereof. Solvent as described in fig. 1. Running 
time for A,B,C: 40 min; for D: SO min. (A) Immunastaining of 
HPLC fraction 113 with mAb HD 66 (B) total GSL staining (see 
section 2) of fraction 113 (C). i~unost~ning of fraction I13 with 
mAb HD 66 (lane a) and with mAb lB2 after sialidase treatment on 
the plate (tane b), (Dj ~~unos~~ng with mAb 1B2 of desiafytated 
fraction 113 (lane a) and approx. 200 ng tactoneotetraosyiceramide 
(lane b). 
3, RESULTS AND DISCUSSION 
Immunostaining patterns of mAb HD 66 and CRIS-4 
are shown in fig.1. Both mAb reacted with several 
A 8 
Fig. 1. lmmunostaining pattern of crude s leucocyte 
monosialogangliosides separated on HPTLC plates in 
chloroform/methanol/water (50:40: 10, v/v/v) containing 0.05% 
(w/v) CaC12; running time, 40 min. Immunosta~ni~~ with mAb HD 
66 (A) and mAb CRIS-4 (B). Bands stained by both mAb are marked 
with arrows. 
monosiaioga~~iosides from human white blood cells. 
MAb CRIS-4 detected gangliosides of higher polarity 
than mAb I-ID 66. Some of rhe bands were shared by 
both mAb (marked with arrows). To characterize the 
antigen detected by HD 66, we fractionated the 
monosialogangliosides by HPLC as described in sec- 
tion 2 (elution profile not shown). Fraction no. 113 con- 
tained only one HD 66-positive band (fig.2A). GSL 
staining showed that other gangliosides were not pre- 
sent in this fraction (fig.2B). After treatment with 
Vibrio cholerae sialidase applied directly on the 
HPTLC plate, HD 66 did not bind to the desialylated 
GSL antigen (fig.2C, lane a). However, the desialylated 
GSL antigen was stained by mAb lB2 (fig,2C, lane b) 
which reacts with tactoneotetraosylceramide (nLc4) and 
its higher type 2 chain homologues such as nLc4, nLc8, 
and nLcl0 [9]. These GSLs have a common 
Gal,& -4GlcNAc@l -R structure at the nonreducing end 
of their carbohydrate chain. We then treated an aliquot 
of HPLC fraction 113 with fibtio cirolerae sialidase 
and compared the product with nLc4 by thin-layer 
chromatogram immunostaining using mAb lB2 
(fig.2D). The desialylated GSL from fraction 113, and 
nLc4 cochromatographed on the HPTLC pi&e, sug- 
gesting that the sialidase-treated GSL of HPLC frac- 
tion 113 was possibly identical to nLc4. To prove this 
348 
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Fig.3. Immunostaining of enzymatically prepared (see section 2) 
2,6-sialosyllactoneotetraosylceramide. Solvent and running time as 
described in fig. 1. Antigens were 0.48 pg (4300 cpm) of 2,6-SPG 
(together with some starting material) (lane a) and 1 pg 
lactoneotetraosylceramide (lane b). lmmunostaining with mAb HD 
66 (A); immunostaining with mAb lB2 (B); autoradiography of 
[“C]NeuAc 2,6-SPG of A lane a (C). 
and to check if sialylated nLc4 was a HD 66 GSL an- 
tigen, we tested both known sialylated forms of nLc4 
for their reaction with HD 66. HD 66 did not bind to 
standard IV3NeuAcnLc4 (data not shown). However, 
enzymatically prepared IV6NeuAcnLc4 was detected by 
HD 66 (fig.3A). Immunostaining with mAb lB2 
showed the presence of some nLc4 starting material in 
the enzymatically formed product (fig.3B, lane a). 
Comparison of an autoradiogram of the 14C-labeled 
IV6NeuAcnLc4 (fig.3C) with its mAb HD 66 immuno- 
stain confirmed that IV6NeuAcnLc4 was one of the HD 
66 antigens. Although the structures of the other HD 
66-positive GSL antigens are not yet known, we obtain- 
ed preliminary information about their partial struc- 
tures (results not shown): neutral GSLs of the lactoneo 
series from leucocytes were separated on two small 
HPTLC plates. When these GSLs were sialylated 
directly on the two plates by 2,6-specific 
sialyltransferase and CMP-NeuAc, two common bands 
were detected by both mAb, HD 66 and CRIS4. Mab 
CRIS-4 stained two additional bands in the more polar 
region of the chromatogram. These 4 bands cor- 
responded to those of the lactoneo-neutral GSL im- 
munostained by lB2. This observation suggests that 
both mAbs detect - although to a different extent - 
gangliosides with a NeuAccu2-6Gal,81-4GlcNAc,& ter- 
minal structure. 
Another mAb, lB9, recognizing the NeuAccu2-6Gal- 
structure has been previously described [ 131. At this 
moment it is not clear if this mAb resembles the CD 76 
mAbs in its reactivity. 
HD 66 and CRIS4 were classified into the CD 76 
group due to their identical cell staining pattern [3]. 
Competitive binding inhibition in a cellular radioim- 
munoassay suggested that both mAbs react with the 
same or a closely associated epitope [ 141. This study 
could now corroborate this observation. Since some 
monosialogangliosides with higher polarity are only 
detected by CRIS-4 and not by HD 66, it may be that 
the mAbs differ in their need for either a short (HD 66) 
or a long (CRIS-4) carbohydrate ‘spacer’ for optimal 
binding. HD 66 also reacted with surface-expressed 
proteins (85 and 67 kDa) of human B lymphocytes [141. 
It is possible that the HD 66 epitope is also present on 
the carbohydrate moiety of glycoproteins. It is not clear 
at present whether the cell specificity of CD 76 mAb is 
due to GSL antigens, glycoprotein antigens, or both. 
The epitope specificity of CD 76 mAbs on glycopro- 
teins is currently investigated. 
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